Potential epigenetic therapeutics for atherosclerosis treatment
Related Experiment Video
Updated: Feb 3, 2026

Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
Ioana Nicorescu1, Geesje M Dallinga1, Menno P J de Winther2
1Department of Vascular Medicine, Academic Medical Centre, Meibergdreef 9, 1105AZ, Amsterdam, the Netherlands.
Abstract:
Notwithstanding the intense efforts into the understanding and prevention of cardiovascular disease (CVD), its complex pathology remains the leading cause of mortality worldwide. The pivotal role of epigenetic changes in the control of gene expression has been profiled in several diseases, such as cancer and inflammatory disorders. In the last decade, increasing evidence has also linked aberrant epigenetic modulation as a contributor to CVD development. Differential profiles of DNA methylation, histone methylation and acetylation have consistently been observed in tissues and cells (comprising the aortic lesions, vascular endothelium and monocytes) from patients with CVD. This highlights the therapeutic potential of epigenetic drugs for cardiovascular treatment.
Insights
Cardiovascular disease (CVD) remains a leading cause of death. Epigenetic changes, including DNA methylation and histone modifications, are increasingly linked to CVD development and offer potential therapeutic targets.
Area of Science:
- Molecular Biology
- Genetics
- Cardiovascular Medicine
Background:
- Cardiovascular disease (CVD) is the primary global cause of mortality despite extensive research.
- Epigenetic modifications, such as DNA methylation and histone alterations, are crucial in regulating gene expression.
- Aberrant epigenetic mechanisms are increasingly recognized as contributors to the complex pathology of CVD.
Purpose of the Study:
- To review the role of epigenetic alterations in the development of cardiovascular disease.
- To highlight the potential of epigenetic drugs as a therapeutic strategy for CVD.
Main Methods:
- Review of current literature on epigenetics and cardiovascular disease.
- Analysis of differential epigenetic profiles (DNA methylation, histone modifications) in CVD-affected tissues and cells.
Main Results:
- Consistent observation of altered DNA methylation, histone methylation, and acetylation in tissues like aortic lesions, vascular endothelium, and monocytes from CVD patients.
- Evidence linking aberrant epigenetic modulation to CVD pathogenesis.
Conclusions:
- Epigenetic dysregulation plays a significant role in cardiovascular disease development.
- Epigenetic drugs represent a promising therapeutic avenue for cardiovascular conditions.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis IV: Nursing Management

